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cardiogenic shock from all published randomized trials (RCTs) to date.
METHODS To identify all RCTs of IABP therapy, public databases
including MEDLINE (1966 to 2014) and EMBASE (1980 to 2014) were
searched. The search was restricted to human studies and clinical
trials or randomized controlled trials only. In addition, we also
manually searched bibliographies of identiﬁed studies if needed.
References were screened for studies that compared the use of IABP in
AMI with or without cardiogenic shock. Data extraction was carried
out independently and in duplicates.
RESULTS Seventeen relevant studies met the inclusion criteria and
3226 participants were enrolled in our study after in-depth review. We
analyzed the impact of IABPmanagement on short-termmortality in 14
trials (2354 patients), long-term mortality in 9 trials (1743 patients).
There was no signiﬁcant difference on short-term mortality (less than
30-day mortality) between IABP on AMI patients with cardiogenic
shock and control group (RR, 0.91; 95% CI, 0.77–1.08; P¼0.293). Similar
result was also observed in AMI patients without cardiogenic shock
(RR, 0.88; 95% CI, 0.60–1.29; P¼0.279). Taken together, the short-term
mortality of patients with AMI with and without cardiogenic shock
does not differ between IABP and control group (RR, 0.90; 95%CI, 0.77–
1.06; p¼0.214). Interestingly, further analysis of two subgroups in 9
studies (4 AMI trials with cardiogenic shock and 5 without cardiogenic
shock) also demonstrated that IABP therapy was not associated with a
signiﬁcantly reduced risk of long-term mortality (6- and 12-month
mortality) rate (RR, 0.91; 95% CI, 0.79–1.04; P ¼0.155). Similar results
were shown when the analyses were performed on patients with (RR,
0.95; 95% CI, 0.83–1.10; P¼0.492) or without cardiogenic shock (RR,
0.73; 95% CI, 0.49–1.09; P¼0.122), respectively.
CONCLUSIONS As far as we know, this is the ﬁrst updated meta-
analysis of only randomized controlled trials including IABP-SHOCK II
trial. We did not observe substantial beneﬁt from IABP use in AMI
patients with or without cardiac shock in reducing the short-term and
long-term mortality rate. However, AMI is not only associated with
compromised cardiac contractile function, especially in patients with
cardiogenic shock. Other than mortality, more comprehensive
assessment of hemodynamic changes or laboratory inﬂammatory
markers may serve as better end points. Therefore, future RCTs with
larger numbers of patients and rigorous design are required.
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OBJECTIVES Endothelial function plays a key role in determining the
clinical manifestations of atherosclerotic lesions. This study aimed to
investigate the relationship between endothelial function and
myocardial perfusion before or after percutaneous coronary inter-
vention (PCI) in patients with non-ST-elevation acute coronary syn-
drome (NSTE-ACS).
METHODS 172 patients, with high-risk NSTE-ACS were measured
levels nitric oxide (NO) and endothelin (ET), and detected the brachial
artery ﬂow-mediated vasodilation (FMD) before PCI. The angiographic
data was analyzed before and after PCI, in terms of TIMI myocardial
perfusion grade in the area of culprit vessels.
RESULTS Before PCI, 78 patients with TMPG 1w2 had lower NO levels
(44.16mmol/L7.46mmol/L vs. 52.25mmol/L5.17mmol/L, P¼0.042),
and lower FMD (2.261.83% vs. 3.451.43%, P¼0.028) than those with
TMPG 2w3, while the levels of ET were not different (p¼0.462). After
PCI, 47 patients with TMPG 1w2 had lower NO levels (42.64mmol/
L8.58mmol/L vs. 54.87mmol/L7.30mmol/L, P¼0.031), and lower FMD
(2.031.25% vs. 3.661.38%, P¼0.020) than those with TMPG 2w3.
CONCLUSIONS Lower NO levels and lower FMD can be measured
before PCI in those high-risk NSTE-ACS patients with poor myocardial
perfusion pre- or post-PCI, which indicated more damaged endothe-
lial function in poor myocardial perfusion patients with NSTE-ACS.
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OBJECTIVES Fractional ﬂow reserve (FFR) is currently considered the
gold standard for evaluating the functional signiﬁcance of coronary
stenosis. However, its potential beneﬁts in real-world practice remain
unknown in China.
METHODS A retrospective cohort study was carried out using the
EMRS database of The Second Afﬁliated Hospital of Zhejiang Univer-
sity, a tertiary and high-volume center in China. Clinical events were
compared using the Cox proportional hazards model during a median
follow-up of 13 months.
RESULTS The study cohort consisted of 366 consecutive patients
referred for coronary revascularization with adjunct FFR and 366
matched controls, from 2010 to 2014. Major adverse cardiac events
(death, myocardial infarction, repeated revascularization, or hospi-
talization for angina) at 4 years were found in 12.0% of angiography-
guided patients and 4.9% in the FFR-guided group (p<0.001). The
mean number of implanted stents was signiﬁcantly lower in FFR
treated subjects (0.520.82 stents) compared with the angiography-
guided group (0.930.96 stents) (P<0.001). No difference in overall
costs at initial hospitalization was observed between angiography-
guided percutaneous coronary intervention (PCI) compared with
FFR-guided PCI (￥33000, range 7393-44700) versus￥21200 (￥19100-
47100) (p¼0.54). How ever, mean costs for major adverse cardiac
events during follow-up were signiﬁcantly reduced in the FFR-guided
arm (￥1688 9554 versus ￥344112873, p<0.001).
CONCLUSIONS In the contemporary clinical practice, FFR-guided PCI
is associated with decreased use of stents, improved clinical outcome,
and reduced costs, compared with angiography-guided PCI.GW26-e4423
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OBJECTIVES To discuss the risk factors and characteristics of coro-
nary artery disease of Han, Uygur and Kazak patients with acute
myocardial infarction in Xinjiang district.
METHODS A retrospective analysis of clinical data of 262 cases of Han
patients, 166 cases of Uygur patients and 86 cases of Kazak patients
was conducted, whose age, body mass index, cholesterol, uric acid,
hypertension, type 2 diabetes, smoking, drinking, family history of
coronary heart disease, relationship between PCI history and patho-
genesis of acute myocardial infarction, and coronary artery disease
characteristics were observed and compared in different groups.
RESULTS Between the Han and minority young patients, there were
statistically signiﬁcant differences in the distribution of BMI, lipo-
protein a, positive family history of coronary heart disease, uric acid
level, the combined aspects of smoking history (P <0.017); there were
also statistically signiﬁcant differences in BMI, TG, HDL-C, apolipo-
protein B, positive family history of coronary heart disease distribu-
tion between minority young patients and older patients (P <0.017).
There were statistically signiﬁcant differences in the distribution of
BMI, TC, HDL-C, LDL-C, apolipoprotein AI, positive family history of
coronary heart disease between Han and Uygur patients (P <0.017).
Han and Kazak patients had statistically signiﬁcant differences in the
distribution of BMI, TC, LDL-C, apolipoprotein B, lipoprotein a, type 2
diabetes and hypertension (P <0.017). Comparison of patients in
Uygur and Kazak showed that there were statistically signiﬁcant dif-
ferences in the distribution of BMI, TC, LDL-C, apolipoprotein AI,
apolipoprotein B and type 2 diabetes between the two groups
(P <0.017). The proportion of zero lesions and single-vessel lesions in
minority youth patients was higher than that of elderly patients
(P <0.001), and the proportion of two and three lesions was less than
that of elderly patients (P <0.001). Gensini score of Han patients was
greater than that of Uygur patients (P <0.001) and the Kazak patients
(P ¼ 0.005); The proportion of Han patients with single-vessel disease
was less than that of Kazak patients (P ¼ 0.003), and the proportion of
patients with double-vessel disease was greater than that of Kazak
patients (P ¼ 0.007). The logistic show that: the risk factors of mi-
nority youth are TG (OR ¼30.793), smoking (OR ¼6.203), hypertension
(OR ¼4.49), hyperuricemia (OR¼2.913) (P <0.05).
CONCLUSIONS There were ethnic differences in risk factors and the
characteristics of coronary artery disease of AMI patients in Xinjiang
